*
home產品介紹Pipeline-Biosimilar

Pipeline 研究時程

Pipeline-Biosimilar

Project Indication Target
Cell clone
Pre-IND
Phase I
Phase II
Phase III
NDA
Launch
LusiNEX (tocilizumab)
view more +
RA, SJIA, PJIA IL-6 receptor
AiNEX (bevacizumab)
view more +
mCRC, MSCLC, mRCC, Glioblastoma, ... VEGF
GranNEX (G-CSF)
view more +
Patients with cancer chemotherapy, ... Recombinant G-CSF
Omalizumab
view more +
Asthma, CIU IgE
Adalimumab
view more +
RA, JIA, PA, AS Adult Crohn's Disease TNF-a
Trastuzumab
view more +
Breast Cancer HER2
scroll to Top